Glenmark Pharmaceuticals : QUARTER 4 Jan 01 – Mar 31 View / Download

Corporate Governance: Quarter ending: March 2021

ANNEXURE I

1. Name of Listed Entity - Glenmark Pharmaceuticals Limited

	2. Quarter ending		- 31-MARCH-2021
		I.	Composition of Board of Directors
Titl	Name	of the Director	DIN		Categ	Date Of Birth	Whether	Date of	Initial Date	Date Of		Date of	Tenur	No of	No of	No of	No of
e						ory		Special	passing	of Appoint-	Reappoint		Resignation	e of	Direct	Indepen	member	post of
(Mr.						(Chair		Resolution	Special	ment	ment			direct	orship	dent	ships in	Chairpers
/						person		passed?	Resolution					or (in	in	Director	Audit/	on in
Ms)											mont	listed	ship in	Stakeho	Audit/sta
					/		[Refer Reg.
												hs)	entitie	listed	lder	keholder
						Execut		17(1A) of
													s	entities	Committ	committe
						ive/		Listing							includi	includin	ee(s)	e held in
						Non-		Regulation]							ng this	g this	includin	listed
						Execut									listed	listed	g this	entity
						ive/									entity	entity	listed	including
																entity	this listed
						Indepen
																	entity
						dent/N
						ominee)
Mrs	Blanche E Saldanha	00007671		NED	04-07-1940	Yes	28-09-2018	14-08-2009	-			-	1	0	0	0
Mr	Glenn Saldanha		00050607		C & ED	26-11-1969	NA	-	12-10-1998	16-05-2017			-	1	0	0	0
Mrs	Cherylann Pinto		00111844		ED	16-01-1967	NA	-	16-05-2007	16-05-2017			-	1	0	1	0
Mr	Rajesh V Desai		00007960		ID	14-07-1958	NA	-	16-05-2002	26-06-2020			9	1	1	1	1
Mr	V.S. Mani		01082878		ED	20-10-1964	NA	-	29-05-2018		-		-	1	0	1	0
Mr	Sridhar Gorthi		00035824		ID	31-07-1972	NA	-	26-04-2005	01-04-2019			191	2	2	3	2
Mr	Devendra Raj Mehta	01067895		ID	25-06-1937	Yes	28-09-2018	14-08-2009	01-04-2019			140	4	4	4	2
Mr	Dr. Brian W Tempest	00101235		ID	13-06-1947	Yes	28-09-2018	30-01-2012	01-04-2019			110	1	1	0	0
Mr	Bernard H Munos	05198283		ID	29-05-1950	NA	-	30-01-2012	01-04-2019			110	1	1	0	0
Mrs	Sona Saira Ramasastry	08398547		ID	28-10-1975	NA	-	01-04-2019	-			24	1	1	1	0
Mr	Dipankar Bhattacharjee	08770548		ID	02-11-1960	NA	-	14-08-2020	-			8	1	1	0	0

1. Composition of Committees

Audit Committee

Sr. No.	Name of the Director	Category	Chairperson/	Date of	Date of
			Membership	Appointment	Resignation
1	Mr. Rajesh V. Desai	ID	Chairperson	13-08-2019	NA
2	Mr. Sridhar Gorthi	ID	Member	26-04-2005	NA
3	Mr. Devendra Raj Mehta	ID	Member	06-11-2020	NA
Stakeholders Relationship Committee
Sr. No.	Name of the Director	Category	Chairperson/	Date of	Date of
			Membership	Appointment	Resignation
1	Mr. Devendra Raj Mehta	ID	Chairperson	06-04-2015	NA
2	Mrs. Cherylann Pinto	ED	Member	27-01-2009	NA
3	Mrs. Sona Saira Ramasastry	ID	Member	26-06-2020	NA
Risk Management Committee
Sr. No.	Name of the Director	Category	Chairperson/	Date of	Date of
			Membership	Appointment	Resignation
1	Mr. Glenn Saldanha	C & ED	Chairperson	30-10-2014	NA
2	Mr. Rajesh V Desai	ID	Member	30-10-2014	NA
3	Mr. Devendra Raj Mehta	ID	Member	06-04-2015	NA
4	Mr. V.S. Mani	ED	Member	14-02-2019	NA
Nomination and Remuneration Committee
Sr. No.	Name of the Director	Category	Chairperson/	Date of	Date of
			Membership	Appointment	Resignation
1	Mr. Sridhar Gorthi	ID	Chairperson	23-01-2007	NA
2	Mr. Glenn Saldanha	ED	Member	31-12-1999	NA
3	Mr. Devendra Raj Mehta	ID	Member	06-04-2015	NA

Corporate Social Responsibility Committee

Sr. No.	Name of the Director	Category	Chairperson/	Date of	Date of
			Membership	Appointment	Resignation
1	Cherylann Pinto	ED	Chairperson	07-05-2013	NA
2	Sridhar Gorthi	ID	Member	07-05-2013	NA
3	Rajesh V. Desai	ID	Member	24-07-2014	NA

1. Meeting of Board of Directors

Date(s) of Meeting (if any) in the	Date(s) of Meeting (if any) in the relevant	Maximum gap between
previous quarter	quarter	any two consecutive (in
		number of days)
06-11-2020	12-02-2021	97

IV.	Meeting of Committees
Name of the committee		Date(s) of	Whether	Date(s) of
			meeting of	requirement	meeting of the
			the committee	of Quorum	committee in
			in the relevant	met	the previous
			quarter	(details)	quarter
Audit Committee		11-02-2021	Yes	05-November-
					2020
Nomination and		12-02-2021	Yes	06- November -
Remuneration Committee				2020
Stakeholders Relationship		12-02-2021	Yes	05- November -
Committee				2020
Risk Management		11-02-2021	Yes	05- November -
Committee				2020
CSR Committee		11-02-2021	Yes	05- November -
					2020

V.	Related Party Transactions
	Subject	Compliance status (Yes/No/NA)
Whether prior approval of audit committee obtained	Yes
Whether shareholder approval obtained for material RPT	NA
Whether details of RPT entered into pursuant to omnibus	Yes
approval have been reviewed by Audit Committee
VI.	Affirmations
1.	The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure	requirements) Regulations, 2015. - Yes
2.	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure	requirements) Regulations, 2015

1. 1. Audit Committee - Yes
   2. Nomination & remuneration committee - Yes
   3. Stakeholders relationship committee - Yes
   4. Risk management committee (applicable to the top 100 listed entities) - Yes
2. The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. - Yes
3. The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.- Yes
4. a. This report and/or the report submitted in the previous quarter has been placed before Board of Directors. - Yes b. Any comments/observations/advice of Board of Directors may be mentioned here: No Comments

Annexure II

Annual Affirmations

Sr	Particulars	Regulation Number	Compliance status
(Yes/No/NA)
1	Independent director(s) have been appointed in terms of specified criteria of 'independence' and/or	16(1)(b) & 25(6)	Yes
'eligibility'
2	Board composition	17(1), 17(1A) & 17(1B)	Yes
3	Meeting of Board of directors	17(2)	Yes
4	Quorum of Board meeting	17(2A)	Yes
5	Review of Compliance Reports	17(3)	Yes
6	Plans for orderly succession for appointments	17(4)	Yes
7	Code of Conduct	17(5)	Yes
8	Fees/compensation	17(6)	Yes
9	Minimum Information	17(7)	Yes
10	Compliance Certificate	17(8)	Yes
11	Risk Assessment & Management	17(9)	Yes
12	Performance Evaluation of Independent Directors	17(10)	Yes
13	Recommendation of Board	17(11)	Yes
14	Maximum number of Directorships	17A	Yes
15	Composition of Audit Committee	18(1)	Yes
16	Meeting of Audit Committee	18(2)	Yes
17	Composition of nomination & remuneration committee	19(1) & (2)	Yes
18	Quorum of Nomination and Remuneration Committee meeting	19(2A)	Yes
19	Meeting of Nomination and Remuneration Committee	19(3A)	Yes
20	Composition of Stakeholder Relationship Committee	20(1), 20(2) & 20(2A)	Yes
21	Meeting of Stakeholders Relationship Committee	20(3A)	Yes
22	Composition and role of risk management committee	21(1),(2),(3),(4)	Yes
23	Meeting of Risk Management Committee	21(3A)	Yes
24	Vigil Mechanism	22	Yes
25	Policy for related party Transaction	23(1),(1A),(5),(6),(7) & (8)	Yes
26	Prior or Omnibus approval of Audit Committee for all related party transactions	23(2), (3)	Yes
27	Approval for material related party transactions	23(4)	NA
28	Disclosure of related party transactions on consolidated basis	23(9)	Yes
29	Composition of Board of Directors of unlisted material Subsidiary	24(1)	Yes